S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Vital Proteins Returns to US Open With High-Stakes Fan Sweepstakes

As the official collagen partner of the US Open, Vital Proteins is betting on the tournament’s most intense moments. The brand is launching a sweepstakes that triggers only if a Main Draw Singles match reaches a final-set tiebreak, offering fans over $250,000 in prizes and wellness investments.

Vital Proteins Returns to US Open With High-Stakes Fan Sweepstakes
Photo: Bio & News

Returning for a second year as the presenting sponsor of the Mixed Doubles Championship, Vital Proteins is deepening its footprint at the USTA Billie Jean King National Tennis Center. The company’s "Final-Set Tiebreak" sweepstakes creates a direct link between match outcomes and fan rewards. Should a tiebreak occur during the quarterfinals or later, entrants become eligible for prizes ranging from collagen supplies to a 2027 US Open finals experience, which includes private helicopter transport.

Tennis professional Jessica Pegula joins the effort as a brand partner, highlighting the role of consistency and physical maintenance in high-level competition. Beyond the sweepstakes, the brand is hosting interactive booths, including a "Collagen Court" challenge to test fan reflexes, and distributing product samples during the Mixed Doubles matches. This multi-year partnership aims to position collagen supplementation as a core component of athletic preparation and everyday recovery for both players and spectators.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!